| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 9.38▲ | 9.41▲ | 9.29▲ | 8.73▲ | 8.53▲ |
| MA10 | 9.22▲ | 9.13▲ | 8.94▲ | 8.31▲ | 8.84▲ |
| MA20 | 8.80▲ | 8.70▲ | 8.53▲ | 8.22▲ | N/A |
| MA50 | 8.24▲ | 8.25▲ | 8.23▲ | 8.85▲ | N/A |
| MA100 | 8.18▲ | 8.29▲ | 8.61▲ | N/A | N/A |
| MA200 | 8.38▲ | N/A | N/A | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.064▲ | N/A | N/A | N/A | N/A |
| RSI | 76.225▲ | 75.222▲ | N/A | N/A | N/A |
| STOCH | 94.671▲ | 97.306▲ | 97.584▲ | 80.284▲ | N/A |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -9.966▲ | N/A |
| CCI | 128.958▲ | 125.307▲ | 146.895▲ | 268.937▲ | N/A |
|
Friday, October 30, 2020 05:41 AM
SANTA MONICA, Calif., Oct. 30, 2020 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or "Company"), a clinical-stage company developing innovative drug ...
|
|
Friday, October 30, 2020 05:10 AM
Oct. 30, 2020 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or "Company"), a clinical-stage company developing innovative drug therapies for liver disease, today announced an interview ...
|
|
Friday, October 30, 2020 05:07 AM
SANTA MONICA, Calif., Oct. 30, 2020 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) ("BioVie" or "Company"), a clinical-stage company developing innovative drug ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/11/20 | 8.94 | 9.888 | 8.81 | 9.65 | 66,000 |
| 27/11/20 | 8.31 | 9.14 | 8.24 | 8.84 | 31,189 |
| 25/11/20 | 8.45 | 8.58 | 8.28 | 8.44 | 33,200 |
| 24/11/20 | 7.75 | 8.70 | 7.75 | 8.43 | 50,300 |
| 23/11/20 | 7.75 | 8.30 | 7.75 | 8.30 | 21,308 |
| 20/11/20 | 7.89 | 8.00 | 7.50 | 7.90 | 21,500 |
| 19/11/20 | 7.88 | 8.00 | 7.88 | 7.88 | 6,500 |
| 18/11/20 | 7.89 | 7.89 | 7.77 | 7.846 | 2,800 |
| 17/11/20 | 7.62 | 8.00 | 7.51 | 8.00 | 21,200 |
| 16/11/20 | 8.125 | 8.177 | 7.55 | 7.86 | 11,100 |
|
|
||||
|
|
||||
|
|